Literature DB >> 9702584

Imiquimod (Aldara cream).

H W Buck1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9702584      PMCID： PMC1784781          DOI： 10.1002/(SICI)1098-0997(1998)6:2<49::AID-IDOG3>3.0.CO;2-2

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN： 1064-7449


× No keyword cloud information.
  7 in total

1.  Effect of imiquimod as an adjuvant for immunotherapy of genital HSV in guinea-pigs.

Authors:  D I Bernstein; C J Harrison; E R Tepe; A Shahwan; R L Miller
Journal:  Vaccine       Date:  1995-01       Impact factor: 3.641

2.  Effects of the immunomodulating agent R837 on acute and latent herpes simplex virus type 2 infections.

Authors:  D I Bernstein; C J Harrison
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

3.  Efficacy of S26308 against guinea pig cytomegalovirus infection.

Authors:  M Chen; B P Griffith; H L Lucia; G D Hsiung
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

4.  Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.

Authors:  L Edwards; A Ferenczy; L Eron; D Baker; M L Owens; T L Fox; A J Hougham; K A Schmitt
Journal:  Arch Dermatol       Date:  1998-01

5.  Effects of therapy with an immunomodulator (imiquimod, R-837) alone and with acyclovir on genital HSV-2 infection in guinea-pigs when begun after lesion development.

Authors:  D I Bernstein; R L Miller; C J Harrison
Journal:  Antiviral Res       Date:  1993-01       Impact factor: 5.970

6.  Posttherapy suppression of genital herpes simplex virus (HSV) recurrences and enhancement of HSV-specific T-cell memory by imiquimod in guinea pigs.

Authors:  C J Harrison; R L Miller; D I Bernstein
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

7.  Cytokine induction by the immunomodulators imiquimod and S-27609.

Authors:  T L Testerman; J F Gerster; L M Imbertson; M J Reiter; R L Miller; S J Gibson; T L Wagner; M A Tomai
Journal:  J Leukoc Biol       Date:  1995-09       Impact factor: 4.962
  7 in total
  1 in total

1.  Safety, efficacy, and patient acceptability of imiquimod for topical treatment of actinic keratoses.

Authors:  Caroline Caperton; Brian Berman
Journal:  Clin Cosmet Investig Dermatol       Date:  2011-04-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.